☆ 4.6 Article

Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Ophthalmology

Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

Javier Zarranz-Ventura et al.

Summary: This study aimed to investigate the visual outcomes of neovascular AMD treated with anti-VEGF drugs at the national level. The results showed that the baseline visual acuity was lower in previously treated eyes compared to treatment naive eyes. The study drugs used included ranibizumab, aflibercept, and bevacizumab. The number of injections and visits also influenced the visual outcomes.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

添加到收藏夹

Review Ophthalmology

AI-based monitoring of retinal fluid in disease activity and under therapy

Ursula Schmidt-Erfurth et al.

Summary: High-resolution three-dimensional optical coherence tomography (OCT) accurately visualizes retinal fluid, which is a major biomarker in exudative macular disease. With the help of artificial intelligence (AI), fully automated tools for OCT imaging have been introduced to identify and quantify fluid, surpassing human experts in terms of accuracy and speed. AI-based fluid analysis allows for better understanding of pathophysiological mechanisms and impact of different treatments on retinal function.

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

添加到收藏夹

Review Ophthalmology

IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Systematic Literature Review

Varun Chaudhary et al.

Summary: Understanding the impact of different fluid compartments on visual acuity is crucial for optimizing treatment outcomes in age-related macular degeneration. This systematic review found that intraretinal fluid negatively affected visual acuity, while the impact of subretinal fluid varied. There was insufficient data on the effects of subretinal pigment epithelial fluid.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2022)

添加到收藏夹

Article Ophthalmology

Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning

Gabriella Moraes et al.

Summary: A deep learning algorithm was applied to analyze OCT scans of eyes with neovascular AMD, revealing significant differences in features between first- and second-treated eyes, as well as among different age groups and ethnicities. The openly available raw segmentation output data may contribute to personalized care and the detection of novel structure-function correlations in real-world settings.

OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry

Marc Figueras-Roca et al.

Summary: The study compared the outcomes of two different antivascular endothelial growth factor treatment regimens for treatment-naive eyes with neovascular age-related macular degeneration in routine clinical care at 12 and 24 months in Spain. The results showed similar visual acuity results with TAE and FB regimens, with no differences in the median number of injections. However, the TAE approach seemed to deliver a wider distribution of injection frequencies due to its individualized approach, which may help reduce the burden of injections in some eyes.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

Manuel Saenz-de-Viteri et al.

Summary: Patients with subretinal fluid (SRF) at the end of the loading phase had better visual outcomes compared to those with intraretinal fluid (IRF). However, the persistence of SRF did not affect visual outcomes across the different treatment regimens. On the other hand, the presence of IRF was associated with poorer visual outcomes, especially in the fixed bimonthly (FBM) group.

ACTA OPHTHALMOLOGICA (2021)

添加到收藏夹

Article Ophthalmology

Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Degeneration

Tiarnan D. L. Keenan et al.

Summary: The study evaluated the use of artificial intelligence algorithms to extract retinal fluid volume data from OCT scans for treatment of NVAMD. The results showed rapid decrease in fluid volumes with anti-VEGF therapy, and the importance of quantitative measures of IRF, SRF, and PED as biomarkers in NV-AMD. Using nanoliters as a convenient unit for consistency between studies is proposed.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Review Ophthalmology

Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations

Laurent Kodjikian et al.

Summary: Current guidelines on the management of neovascular age-related macular degeneration (nAMD) do not provide clear recommendations on the interpretation of fluid seen on optical coherence tomography (OCT) imaging. This study reviewed current guidelines and evidence on the role of fluid as a biomarker in nAMD management, developing a clinically oriented algorithm based on expert consensus. The findings emphasize the importance of fluid as a critical biomarker for disease activity in nAMD diagnosis and management.

EYE (2021)

添加到收藏夹

Article Ophthalmology

EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial

Paul Mitchell et al.

Summary: The study compared the efficacy of early-start vs. late-start intravitreal aflibercept treat-and-extend (T&E) regimens in patients with neovascular age-related macular degeneration. The outcomes showed similar visual and anatomical results between the two groups over a two-year period, with only one injection difference.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Article Ophthalmology

Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning

Irmela Mantel et al.

Summary: The study developed a reliable algorithm using deep-learning for automated identification, localization, and volume measurement of exudative manifestations in neovascular age-related macular degeneration. The algorithm demonstrated good performance with high accuracy and repeatability in detecting and measuring intraretinal fluid, subretinal fluid, and pigment epithelium detachment.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)

添加到收藏夹

Article Ophthalmology

Predicting Incremental and Future Visual Change in Neovascular Age-Related Macular Degeneration Using Deep Learning

Dun Jack Fu et al.

Summary: This study evaluated the predictive usefulness of quantitative imaging biomarkers acquired automatically from OCT scans in patients with neovascular AMD undergoing anti-VEGF therapy. The results indicate the potential of these biomarkers to predict visual outcomes and inform treatment decisions for personalized medicine.

OPHTHALMOLOGY RETINA (2021)

添加到收藏夹

Article Ophthalmology

Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration

Usha Chakravarthy et al.

EYE (2020)

添加到收藏夹

Article Ophthalmology

Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration

Ursula Schmidt-Erfurth et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results

Robyn H. Guymer et al.

OPHTHALMOLOGY (2019)

添加到收藏夹

Article Ophthalmology

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease

Peter J. Kertes et al.

OPHTHALMOLOGY (2019)

添加到收藏夹

Review Ophthalmology

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

Hemal Mehta et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2018)

添加到收藏夹

Article Ophthalmology

Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration

Ian A. Rodrigues et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV Incidence of Blindness and Sight Impairment in Ranibizumab-Treated Patients

Robert L. Johnston et al.

OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study

Jennifer J. Arnold et al.

BMC OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom

M. Buckle et al.

EYE (2015)

添加到收藏夹

Review Ophthalmology

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)

Ursula Schmidt-Erfurth et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2014)

添加到收藏夹

Article Ophthalmology

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

Juan E. Grunwald et al.

OPHTHALMOLOGY (2014)

添加到收藏夹

Article Ophthalmology

EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASES The Fight Retinal Blindness! Project

Mark C. Gillies et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)

添加到收藏夹

Letter Ophthalmology

Predictors of AMD Treatment Response

Sanjeewa S. Wickremasinghe et al.

OPHTHALMOLOGY (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.